Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: limit who wrote (894)	5/20/1999 6:55:00 PM
From: scaram(o)uche	Respond to of 1073

The "Bio" meetings are not very high powered. I usually throw the mailers in the trash without even looking at them. For future notice and IMO, there's rarely news of much significance ass'd with the meeting. Haven't had a chance to look at the Eisinger article yet. Will try to do such this evening. The only thing that I can say, in advance, is that I can remember calling three "best buys" in biotech......... AGPH in misc.invest.stocks, and GLIA and (recently) BTRN here. If you hang out with a bunch of scientist investors and do a good job at analysis/listening, you can make tons of good money in the lower tiers. Big science companies with leveraged business plans are, with few exceptions, cheap. If TSC can't find them, I can and will. There was actually a second cheap shot taken at the lower tiers today, and this time it's laughable (David Saks)........ biz.yahoo.com